Prevest Denpro Ltd

AI
Prevest Denpro Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents
AI

Prevest Denpro Ltd

₹ 405 4.23%
21 Aug - close price
prevestdenpro.com BSE - SME: 543363
About

Incorporated in 2000, Prevest DenPro Limited is into development and manufacturing of dental materials used for diagnosis, prevention and treatment of dental conditions. Company is heavily export-oriented.

Key Points

Product Portfolio[1]
The company offers over 100 dental products across:
a) Restorative Materials:
Cavity restoration solutions.
b) Endodontic Solutions:
Root canal treatment
materials.
c) Preventive Care:
Post-extraction and decay
prevention products.
d) Orthodontic Adhesives:
Bonding solutions for braces
and aligners.
e) Impression Materials & Cements:
Impression and cementation products.

Website BSE
  • Market Cap ₹ 487 Cr.
  • Current Price ₹ 405
  • High / Low ₹ 622 / 318
  • Stock P/E 21.6
  • Book Value ₹ 105
  • Dividend Yield 0.25 %
  • ROCE 24.9 %
  • ROE 18.5 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Equipment & Supplies Medical Equipment & Supplies

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
13.39 13.18 13.62 16.24 13.34 16.26 14.93 18.54 15.72 18.66 18.37 18.90 19.44
8.43 8.68 9.15 10.36 8.85 10.45 9.79 11.91 10.19 11.96 12.15 11.81 12.55
Operating Profit 4.96 4.50 4.47 5.88 4.49 5.81 5.14 6.63 5.53 6.70 6.22 7.09 6.89
OPM % 37.04% 34.14% 32.82% 36.21% 33.66% 35.73% 34.43% 35.76% 35.18% 35.91% 33.86% 37.51% 35.44%
0.61 0.74 0.68 0.84 0.86 1.07 1.10 1.08 1.17 1.20 1.16 1.46 1.33
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 0.17 0.22 0.42 0.46 0.48 0.47 0.48 0.47 0.49 0.50 0.51 0.50 0.52
Profit before tax 5.40 5.02 4.73 6.26 4.87 6.41 5.76 7.24 6.21 7.40 6.87 8.05 7.70
Tax % 24.26% 25.70% 23.26% 25.56% 25.26% 24.49% 22.40% 27.49% 25.44% 24.73% 25.04% 24.72% 24.94%
4.08 3.74 3.64 4.66 3.65 4.84 4.46 5.25 4.63 5.57 5.15 6.06 5.78
EPS in Rs 3.40 3.12 3.03 3.88 3.04 4.03 3.72 4.37 3.86 4.64 4.29 5.05 4.82
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
19 23 28 38 50 56 63 72 75
15 17 19 23 30 36 41 46 48
Operating Profit 4 5 9 15 20 20 22 26 27
OPM % 20% 23% 32% 40% 40% 36% 35% 36% 36%
0 2 1 2 2 3 4 5 5
Interest 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 1 1 1 2 2 2
Profit before tax 4 6 9 16 21 21 24 29 30
Tax % 20% 20% 23% 28% 25% 25% 25% 25%
3 5 7 12 16 16 18 21 23
EPS in Rs 1,049.12 1,757.89 252.98 9.64 13.09 13.43 15.16 17.85 18.80
Dividend Payout % 0% 0% 0% 0% 8% 7% 7% 6%
Compounded Sales Growth
10 Years: %
5 Years: 20%
3 Years: 13%
TTM: 15%
Compounded Profit Growth
10 Years: %
5 Years: 24%
3 Years: 11%
TTM: 18%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: -4%
1 Year: -28%
Return on Equity
10 Years: %
5 Years: 21%
3 Years: 19%
Last Year: 19%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 0.29 0.29 0.29 12 12 12 12 12
Reserves 10 15 22 45 61 77 94 114
1 2 1 1 0 0 0 0
4 4 7 6 6 6 7 8
Total Liabilities 15 21 31 64 79 95 113 134
5 5 5 7 7 27 27 27
CWIP 0 0 2 5 17 0 0 0
Investments 0 0 0 1 1 2 5 9
10 16 23 52 53 66 81 98
Total Assets 15 21 31 64 79 95 113 134

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
3 5 9 7 10 11 15 16
-1 -1 -2 -4 -12 -2 -2 -2
0 0 -1 23 -1 -0 -1 -1
Net Cash Flow 2 4 6 26 -3 9 12 12
Free Cash Flow 2 4 7 2 -3 8 13 14
CFO/OP 96% 115% 118% 75% 79% 80% 94% 87%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 46 35 48 22 31 53 45 45
Inventory Days 28 59 59 122 139 162 208 235
Days Payable 70 72 181 61 40 34 42 54
Cash Conversion Cycle 4 22 -74 83 130 181 211 227
Working Capital Days 10 20 3 41 64 80 81 89
ROCE % 45% 47% 40% 32% 27% 25% 25%

Insights

In beta
Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Number of Countries Exported To
Countries (approx.)

Log in to view insights

Please log in to see hidden values.

Login
Number of Dealers in India
Dealers (approx.)
Number of Overseas Agents
Overseas Agents (approx.)
Number of Permanent Employees
Employees
Capacity Utilization
%
Installed Capacity
MT per annum
Domestic Revenue Share
% of Revenue from Operations
R&D Expenditure (Percentage of Turnover)
%

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
73.60% 73.60% 73.60% 73.60% 73.60% 73.60% 73.60% 73.60% 73.60% 73.60% 73.60% 73.60%
0.31% 0.31% 0.52% 1.11% 0.63% 0.63% 0.63% 0.63% 0.63% 0.65% 0.65% 0.65%
0.71% 0.68% 0.68% 0.68% 0.68% 0.71% 1.28% 1.22% 0.75% 0.77% 0.77% 0.79%
25.37% 25.40% 25.20% 24.61% 25.09% 25.07% 24.49% 24.54% 25.01% 24.97% 24.97% 24.94%
No. of Shareholders 1,9372,0401,9911,8961,8221,8321,8871,9281,8881,9571,9601,975

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Concalls